Elraglusib (9-ING-41) is a potent inhibitor of glycogen synthase kinase-3 (GSK-3) with antitumor activity. Elraglusib induces apoptosis and cell cycle arrest at prophase by targeting centrosomes and microtubule-bound GSK3beta.
Molecular Weight:
404.35
Purity:
>99%
CAS Number:
[1034895-42-5]
Formula:
C22H13FN2O5
Target:
GSK-3
* VAT and and shipping costs not included. Errors and price changes excepted